Patient self-reported adherence to ritonavir-boosted darunavir combined with either raltegravir or tenofovir disoproxil fumarate/emtricitabine in the NEAT001/ANRS143 Trial
-
Ammassari, Adriana (IRCCS)
;
Stöhr, Wolfgang (Medical Research Council Clinical Trials Unit at UCL) ;
Antinori, Andrea (IRCCS) ;
Molina, Jean-Michel (University of Paris Diderot) ;
Schwimmer, Christine (University of Bordeaux) ;
Domingo, Pere (Institut d'Investigació Biomèdica Sant Pau) ;
Thalme, Anders (Karolinska University Hospital and Karolinska Institutet (Suecia)) ;
Di Pietro, Massimo (S. Maria Annunziata Hospital) ;
Wallet, Cedrik (University of Bordeaux) ;
Pozniak, Anton (Chelsea and Westminster NHS Trust St Stephens Centre) ;
Richert, Laura (University of Bordeaux) ;
Raffi, François (INSERM CIC 1413. CHU) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
